Pacira BioSciences' Retained Earnings rose 9.64% to -$201.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$201.0 million, marking a year-over-year increase of 9.64%. This contributed to the annual value of -$206.4 million for FY2024, which is 93.22% down from last year.
Pacira BioSciences' Retained Earnings amounted to -$201.0 million in Q3 2025, which was up 2.63% from -$206.4 million recorded in Q2 2025.
Pacira BioSciences' 5-year Retained Earnings high stood at -$78.9 million for Q2 2024, and its period low was -$243.5 million during Q1 2021.
Its 3-year average for Retained Earnings is -$160.3 million, with a median of -$168.3 million in 2023.
Per our database at Business Quant, Pacira BioSciences' Retained Earnings surged by 44.62% in 2024 and then plummeted by 161.48% in 2025.
Quarterly analysis of 5 years shows Pacira BioSciences' Retained Earnings stood at -$211.9 million in 2021, then grew by 29.80% to -$148.8 million in 2022, then rose by 28.20% to -$106.8 million in 2023, then slumped by 93.22% to -$206.4 million in 2024, then climbed by 9.64% to -$201.0 million in 2025.
Its Retained Earnings stands at -$201.0 million for Q3 2025, versus -$206.4 million for Q2 2025 and -$201.5 million for Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value